PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26687339-9	2016	RESULTS: The combination of ezetimibe plus rosuvastatin decreased total cholesterol, low-density lipoprotein cholesterol, hsCRP, IL-6, and MMP-9 levels at six and 12 months after treatment.	Ezetimibe	28-37	matrix metallopeptidase 9	Homo sapiens	139-144	
20880729-8	2011	Ezetimibe was associated with a significant reduction in aortic wall MMP-9 (p = 0.02) and aortic wall IL-6 (p = 0.02), associated with a reduction in plasma lipids.	Ezetimibe	0-9	matrix metallopeptidase 9	Homo sapiens	69-74